A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain
Public ClinicalTrials.gov record NCT05359133. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT05359133
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Wex Pharmaceuticals Inc.
- Industry
- Enrollment
- 35 participants
Conditions and interventions
Interventions
- Tetrodotoxin Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 18, 2022
- Primary completion
- Oct 13, 2024
- Completion
- Oct 13, 2024
- Last update posted
- Feb 19, 2025
2022 – 2024
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Syrentis Clinical Research | Santa Ana | California | 92705 | — |
| Providence Medical Foundation | Santa Rosa | California | 95403 | — |
| MEDSOL Clinical Research Center | Port Charlotte | Florida | 33952 | — |
| Care Access Research | Macon | Georgia | 31201 | — |
| Paradigm Clinical Research | Boise | Idaho | 83709 | — |
| Clinical Trials of SWLA | Lake Charles | Louisiana | 70601 | — |
| Barbara Ann Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| St Luke's Hospital of Kansas City | Kansas City | Missouri | 64111 | — |
| Care Access Research | Clifton | New Jersey | 07013 | — |
| ES Clinical Research Group | Garden City | New York | 11530 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | — |
| Oncology Specialists of Charlotte | Charlotte | North Carolina | 28207 | — |
| Oklahoma Cancer Specialists and Research Institute (OCSRI) | Tulsa | Oklahoma | 74146 | — |
| Center for Oncology and Blood Disorders (COBD) | Houston | Texas | 77030 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05359133, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 19, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05359133 live on ClinicalTrials.gov.